Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4170662
Max Phase: Preclinical
Molecular Formula: C74H104N20O18S2
Molecular Weight: 1625.90
Molecule Type: Unknown
Associated Items:
ID: ALA4170662
Max Phase: Preclinical
Molecular Formula: C74H104N20O18S2
Molecular Weight: 1625.90
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC[C@H](C)[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2ccc3ccccc3c2)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H]2CSSC[C@H](NC1=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N2
Standard InChI: InChI=1S/C74H104N20O18S2/c1-4-39(2)58-68(108)89-51-37-113-114-38-52(88-61(101)45(19-10-26-79-73(75)76)82-56(97)35-81-60(100)47(34-57(98)99)84-66(106)53-21-12-28-92(53)70(110)48(86-64(51)104)32-41-15-6-5-7-16-41)65(105)91-59(40(3)96)69(109)83-46(20-11-27-80-74(77)78)62(102)87-50(36-95)63(103)85-49(33-42-24-25-43-17-8-9-18-44(43)31-42)71(111)94-30-14-23-55(94)72(112)93-29-13-22-54(93)67(107)90-58/h5-9,15-18,24-25,31,39-40,45-55,58-59,95-96H,4,10-14,19-23,26-30,32-38H2,1-3H3,(H,81,100)(H,82,97)(H,83,109)(H,84,106)(H,85,103)(H,86,104)(H,87,102)(H,88,101)(H,89,108)(H,90,107)(H,91,105)(H,98,99)(H4,75,76,79)(H4,77,78,80)/t39-,40+,45-,46-,47-,48-,49-,50-,51-,52-,53-,54-,55-,58-,59-/m0/s1
Standard InChI Key: DRMCRYSYJGXXTH-LEBNSUCRSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1625.90 | Molecular Weight (Monoisotopic): 1624.7279 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. de Veer SJ, Li CY, Swedberg JE, Schroeder CI, Craik DJ.. (2018) Engineering potent mesotrypsin inhibitors based on the plant-derived cyclic peptide, sunflower trypsin inhibitor-1., 155 [PMID:29936356] [10.1016/j.ejmech.2018.06.029] |
Source(1):